Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biomarin Pharmaceutical (BMRN) Q2 2023 Earnings
BMRN
26
Apr
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.07
0.04
0.16
0.27
Details
Expected EPS
0.21
Actual EPS
0.27
Surprise EPS
0.06
Surprise Percent
+28.57%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of 0.27 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login